In a report that came out on ESPN.com today, the Nevada State Athletic Commission (NSAC) has moved to extend the temporary suspension of UFC light heavyweight Jon Jones (22-1 MMA). They also revealed the substances that Jones tested positive for that caused him to be pulled from his scheduled UFC 200 bout against Daniel Cormier.
Jones, who trains out of Jackson-Wink MMA in Albuquerque, NM, denied taking any banned substances. However, the NSAC filed a complaint that an out of competition sample that Jones provided on June 16 tested positive for an anti-estrogen substance named clomiphene as well as traces of letrozole, which is an aromatase inhibitor. Once Jones was pulled from UFC 200, he and his agent Malki Kawa requested a test of the B-sample from June 16, and the results of that test confirmed the presence of the substances. The Nevada district attorney’s office has preliminarily scheduled a hearing for September or October.
Jones, who had never tested positive for a banned substance until now, was pulled from the scheduled UFC 200 bout three days prior to the event. He is not contesting the temporary ban, but does face a two year suspension under UFC’s drug policy and the United States Anti Doping Agency as well as any punishment under the NSAC jurisdiction. According to Kawa, the team does plan to fight any potential suspension.